SEC 13F Intelligence

Alpine Associates Management Inc. / AMED

Alpine Associates Management Inc.’s Amedisys Inc Position

Does Alpine Associates Management Inc. own Amedisys Inc (AMED)? Not currently — the last reported position was 1.10M shares worth $108M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$108M
Q2 2025
Shares
1.10M
% of Portfolio
+5.76%
Quarters Held
9
position exited

Position History AMED

Reported value by quarter
Q2 ’23: $64MQ2 ’23Q3 ’23: $97MQ4 ’23: $121MQ4 ’23Q1 ’24: $117MQ2 ’24: $118MQ2 ’24Q3 ’24: $83MQ4 ’24: $81MQ4 ’24Q1 ’25: $92MQ2 ’25: $108MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20251.10M$108M+5.76%
Q1 2025992.1K$92M+4.81%
Q4 2024888.1K$81M+4.89%
Q3 2024860.7K$83M+3.81%
Q2 20241.28M$118M+5.62%
Q1 20241.27M$117M+4.56%
Q4 20231.27M$121M+6.20%
Q3 20231.03M$97M+5.06%
Q2 2023705.2K$64M+2.90%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Alpine Associates Management Inc.’s full portfolio or all institutional holders of AMED.